Member Info for neilrich3

I'd agree, the Novacyt Board have no idea what Biosynex's true intention might be.

Perhaps DA has another RNS lined up for Monday @ 7am :)

Stream of large buys this past couple of mins!

Thanks Larry.

Have to wonder whether we have partnered with QuantumMDX

https://www.quantumdx.com/about-us/

The QuantuMDX instrument is cartridge based. 'Real time testing using disposable cartridges' another line from the linkedin photo.

Checking the photos for the London event upon Linkedin....what's Co-Dx?
'lab quality testing'
'One Simple Device'
'Designed for home and point of care settings'
'Smartphone Connectivity to the instrument'
'Subject to FDA Review Not Currently For Sale'

Clearly something new and not a Q16/Q32.

Agreed Kaeren, I'm sure that our CEO has far bigger fish to fry and I'd be disappointed to see him at such a trade event.

The RANDOX shop upon High Street Kensington is always busy, yesterday the customers were queuing out the door. Although the DAM shop Shepherds Bush/Holland Park roundabout is always very quiet.

I'm in Kensington all next week, wonder whether I shall be able to attend, or invitation only?

In my opinion the NCYT board have no idea as to why Biosynex have been building a position, if they did know, they'd have to inform the market. The BOD are in the dark as to their intentions.

Why the obsession with RNS? New and existing customers are not waiting for the next RNS to drop, Novacyt will be proceeding with 'laser focus' and targeting directly those customers most likely to purchase Co-prep. I fully support the paid article within the open access Government publication, I'm sure that we shall hear more about the launch in due course.

https://novacyt.com/about-novacyt-group/

Check the timeline within the Group History, it's there in 2005, however Plasmatec not mentioned since. Also, the relaunch of Plasmatec would go against what DA announced at the end of January, the possibility of streamlining the group under the one brand.

Unfortunately....it's really old, some of the documents are dated 2008...2012, for a moment thought that you might have been on to something.

Link not working for me :(

My money is on Biosynex being our LFT partner, would explain why they have been buying our shares, they are after two bites of the Cherry! First they supply the LFT to Novacyt and then they benefit as major shareholder, should a major sales contract land.

Sarah Humphreys has posted another vacancy upon Linkedin this evening for an Account Manager:
Due to the ongoing success and growth of Novacyt, we are now looking to strengthen our UK clinical sales team. We have amazing opportunities for sales professionals with a proven track record of clinical sales performance into the NHS and B2B.

Not had chance to read Today's posts, therefore this may have been mentioned, however perhaps Biosynex are looking to organise a simple partnership and place a massive order where NCYT supply OEM product to the French.

via Linkedin and the connections between Novacyt employees and Chartwell, it is pretty obvious that we've been working very closely.

From Sarah's CV
Providing businesses the skills to make that next step with a highly motivated, engaged and effective team following a bespoke strategy.

Expert in training and coaching particularly for developing and established sales teams; and 1:1 coaching for peers keen to enhance their skill set.

Proven evidence of:
- recruiting, retaining and developing successful sales teams
- developing market access strategies, product launch & roll out; and how to secure government reimbursement
- developing future Senior Managers from internal talent pool

Experienced in the fields of medical devices, manufacturing and catering.

https://www.linkedin.com/in/sarah-humphreys-8b617523/?originalSubdomain=ukSarah Humphreys
Sarah Humphreys
Experienced Commercial Sales Leader and Coach